← All Compass Pathways PLC filings

Compass Pathways PLC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
CMPS
Compass Pathways PLC
10-K: COMPASS Pathways Achieves Phase 3 Milestones, Secures Funding
COMPASS Pathways reports positive Phase 3 results for COMP360 psilocybin in TRD, initiates PTSD trial, and strengthens financial position with recent capital raises.
NASDAQ
CMPS
Compass Pathways PLC
10-K: COMPASS Pathways Reports Annual Results, Nears Completion of Key Clinical Trial
COMPASS Pathways plc files its 10-K, highlighting progress in its Phase 3 program for COMP360 and plans for a late-stage PTSD program.
NASDAQ
CMPS
Compass Pathways PLC
10-K: COMPASS Pathways Appoints Interim CFO, Details Employment Terms and Files Annual Report
COMPASS Pathways appoints an interim CFO, Mary-Rose Hughes, and outlines her compensation, while also filing its annual report on Form 10-K, detailing financial performance and future outlook.